Prognostic Role of Immune Markers in Triple Negative Breast Carcinoma

Sahin O., Ugurlu M. Ü. , Yumuk P. F. , Kaya H.

PATHOLOGY & ONCOLOGY RESEARCH, vol.26, no.4, pp.2733-2745, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 4
  • Publication Date: 2020
  • Doi Number: 10.1007/s12253-020-00874-4
  • Page Numbers: pp.2733-2745
  • Keywords: Triple negative breast cancer, Tumor infiltrating lymphocytes, Tumor associated macrophages, PD-L1, Fork head box protein 3, Immunohistochemistry, TUMOR-INFILTRATING LYMPHOCYTES, FOXP3 EXPRESSION, POOR-PROGNOSIS, T-CELLS, CLINICAL-SIGNIFICANCE, PD-L1 EXPRESSION, CANCER SUBTYPES, MACROPHAGES, IDENTIFICATION, SURVIVAL


Tumor immune microenvironment (TIME) is a significant prognostic parameter for triple negative breast carcinomas (TNBC) due to being a target for immunotherapeutic agents and its essential role during the cancer immunoediting process. In this study, CD8, FOXP3, CD163, PD-L1/SP142 and PD-L1/SP263 antibodies were examined in a sample of 51 TNBC cases. Patients who received neoadjuvant therapy were excluded. CD8, FOXP3 and CD163 antibodies were evaluated separately in intratumoral area (ITA) and tumor stroma (TS). PD-L1 status was also examined in tumor cells (TC) and immune cells (IC) using both SP142 and SP263 antibodies. In multivariate Cox regressions, the only antibody that was found to be significantly associated with survival was SP142. SP142-positivity in TC and IC was related to increased overall survival. Higher CD163 expression in ITA and SP263-positivity in IC were associated with younger age. Lymphatic/angioinvasion was more frequent in cases with negative/low CD8 and FOXP3 expressions. Moreover, metastatic axillary lymph node(s) was associated with negative/low FOXP3 expression in TS. CD8, FOXP3, CD163, SP142 and SP263 expressions were positively correlated with each other, except a mild discordance caused by CD163 in ITA. Although PD-L1 status with both SP142 and SP263 antibodies were concordant in the majority of cases, 33.3% and 13.7% of the cases showed SP142-negative/SP263-positive pattern in TC and IC respectively. In conclusion, we suggest that composition, density and localization of the immune cells and the check point molecules are important prognostic parameters in TNBC. Immunohistochemistry can be used as an accessible and less expensive tool to demonstrate TIME.